216 related articles for article (PubMed ID: 30682171)
1. Interaction of two antitumor peptides with membrane lipids - Influence of phosphatidylserine and cholesterol on specificity for melanoma cells.
Wodlej C; Riedl S; Rinner B; Leber R; Drechsler C; Voelker DR; Choi JY; Lohner K; Zweytick D
PLoS One; 2019; 14(1):e0211187. PubMed ID: 30682171
[TBL] [Abstract][Full Text] [Related]
2. Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine.
Riedl S; Rinner B; Schaider H; Lohner K; Zweytick D
Biometals; 2014 Oct; 27(5):981-97. PubMed ID: 24838743
[TBL] [Abstract][Full Text] [Related]
3. Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies.
Grissenberger S; Riedl S; Rinner B; Leber R; Zweytick D
Biochim Biophys Acta Biomembr; 2020 Aug; 1862(8):183264. PubMed ID: 32151609
[TBL] [Abstract][Full Text] [Related]
4. Human lactoferricin derived di-peptides deploying loop structures induce apoptosis specifically in cancer cells through targeting membranous phosphatidylserine.
Riedl S; Leber R; Rinner B; Schaider H; Lohner K; Zweytick D
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt A):2918-31. PubMed ID: 26239537
[TBL] [Abstract][Full Text] [Related]
5.
Riedl S; Rinner B; Schaider H; Liegl-Atzwanger B; Meditz K; Preishuber-Pflügl J; Grissenberger S; Lohner K; Zweytick D
Oncotarget; 2017 Sep; 8(42):71817-71832. PubMed ID: 29069749
[TBL] [Abstract][Full Text] [Related]
6. Effect of L- to D-Amino Acid Substitution on Stability and Activity of Antitumor Peptide RDP215 against Human Melanoma and Glioblastoma.
Maxian T; Gerlitz L; Riedl S; Rinner B; Zweytick D
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445175
[TBL] [Abstract][Full Text] [Related]
7. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell-selective cytotoxic effect and inspires the production of "clickable" anticancer peptide in Escherichia coli.
Pasupuleti R; Riedl S; Saltor Núñez L; Karava M; Kumar V; Kourist R; Turnbull WB; Zweytick D; Wiltschi B
Protein Sci; 2023 Dec; 32(12):e4830. PubMed ID: 37916438
[TBL] [Abstract][Full Text] [Related]
8. Melanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa.
Wang C; Chen YW; Zhang L; Gong XG; Zhou Y; Shang DJ
J Drug Target; 2016; 24(6):548-56. PubMed ID: 26596643
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive lipid binding and activity validation of a cancer-specific peptide-peptoid hybrid PPS1.
Desai TJ; Udugamasooriya DG
Biochem Biophys Res Commun; 2017 Apr; 486(2):545-550. PubMed ID: 28322795
[TBL] [Abstract][Full Text] [Related]
10. Phosphatidylserine lipids and membrane order precisely regulate the activity of Polybia-MP1 peptide.
Alvares DS; Ruggiero Neto J; Ambroggio EE
Biochim Biophys Acta Biomembr; 2017 Jun; 1859(6):1067-1074. PubMed ID: 28274844
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of endotoxin neutralization by coupling of a C12-alkyl chain to a lactoferricin-derived peptide.
Andrä J; Lohner K; Blondelle SE; Jerala R; Moriyon I; Koch MH; Garidel P; Brandenburg K
Biochem J; 2005 Jan; 385(Pt 1):135-43. PubMed ID: 15344905
[TBL] [Abstract][Full Text] [Related]
12. The antibiotic and DNA-transfecting peptide LAH4 selectively associates with, and disorders, anionic lipids in mixed membranes.
Mason AJ; Martinez A; Glaubitz C; Danos O; Kichler A; Bechinger B
FASEB J; 2006 Feb; 20(2):320-2. PubMed ID: 16352649
[TBL] [Abstract][Full Text] [Related]
13. PE and PS Lipids Synergistically Enhance Membrane Poration by a Peptide with Anticancer Properties.
Leite NB; Aufderhorst-Roberts A; Palma MS; Connell SD; Ruggiero Neto J; Beales PA
Biophys J; 2015 Sep; 109(5):936-47. PubMed ID: 26331251
[TBL] [Abstract][Full Text] [Related]
14. The NK-lysin derived peptide NK-2 preferentially kills cancer cells with increased surface levels of negatively charged phosphatidylserine.
Schröder-Borm H; Bakalova R; Andrä J
FEBS Lett; 2005 Nov; 579(27):6128-34. PubMed ID: 16269280
[TBL] [Abstract][Full Text] [Related]
15. Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers.
Zhao H; Jutila A; Nurminen T; Wickström SA; Keski-Oja J; Kinnunen PK
Biochemistry; 2005 Mar; 44(8):2857-63. PubMed ID: 15723529
[TBL] [Abstract][Full Text] [Related]
16. Modulated mechanism of phosphatidylserine on the catalytic activity of Naja naja atra phospholipase A2 and Notechis scutatus scutatus notexin.
Chiou YL; Lin SR; Hu WP; Chang LS
Toxicon; 2014 Dec; 92():113-22. PubMed ID: 25449100
[TBL] [Abstract][Full Text] [Related]
17. In search of a novel target - phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy.
Riedl S; Rinner B; Asslaber M; Schaider H; Walzer S; Novak A; Lohner K; Zweytick D
Biochim Biophys Acta; 2011 Nov; 1808(11):2638-45. PubMed ID: 21810406
[TBL] [Abstract][Full Text] [Related]
18. Comparison of patient-derived high and low phosphatidylserine-exposing colorectal carcinoma cells in their interaction with anti-cancer peptides.
Wilms D; Andrä J
J Pept Sci; 2017 Jan; 23(1):56-67. PubMed ID: 28066958
[TBL] [Abstract][Full Text] [Related]
19. Human opioid peptide Met-enkephalin binds to anionic phosphatidylserine in high preference to zwitterionic phosphatidylcholine: natural-abundance 13C NMR study on the binding state in large unilamellar vesicles.
Kimura T
Biochemistry; 2006 Dec; 45(51):15601-9. PubMed ID: 17176081
[TBL] [Abstract][Full Text] [Related]
20. Chondrocytes utilize a cholesterol-dependent lipid translocator to externalize phosphatidylserine.
Damek-Poprawa M; Golub E; Otis L; Harrison G; Phillips C; Boesze-Battaglia K
Biochemistry; 2006 Mar; 45(10):3325-36. PubMed ID: 16519527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
